Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study

Authors

Amir Toor MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2-2024

Volume

30

Issue

2

First Page

82

Last Page

83

Published In/Presented At

10.1016/j.jtct.2023.12.134

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Lehigh Valley Topper Cancer Institute

Document Type

Article